Evidence map›Paper›PMID 34535076›Full record

ArticleThe journal of headache and pain2021

Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis.

David García-Azorín, Thien Phu Do, Andreas R Gantenbein, Jakob Møller Hansen, Marcio Nattan P Souza, Mark Obermann, Heiko Pohl, Christoph J Schankin, Henrik Winther Schytz, Alexandra Sinclair and 2 more

Open access · goldAbstract read
In one paragraph

Article in The journal of headache and pain, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Review
  7. Article
  8. Health equity, care access and quality in headache - part 1.The journal of headache and pain · 2024
    Review
  9. Article
  10. Observational
  11. Review
  12. Article
  13. A review of neurological side effects of COVID-19 vaccination.European journal of medical research · 2023
    Review
  14. COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache.International journal of environmental research and public health · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 8 countries.

David García-AzorínHeadache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Thien Phu DoThe Danish Headache Center, Department of Neurology, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Andreas R GantenbeinDepartment of Neurology and Neurorehabilitation, ZURZACH Care, Bad Zurzach, Switzerland.
Jakob Møller HansenDanish Headache Center, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Marcio Nattan P SouzaDepartment of Neurology, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Mark ObermannDepartment of Neurology, Hospital Weser-Egge, Höxter, Germany.
Heiko PohlDepartment of Neurology, University Hospital Zurich, Zurich, Switzerland.
Christoph J SchankinDepartment of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Henrik Winther SchytzDanish Headache Center, Rigshospitalet-Glostrup, Faculty of Health Sciences, University of Copenhagen, Glostrup, Denmark.
Alexandra SinclairMetabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Guus G Schoonman *Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Espen Saxhaug Kristoffersen *Department of Neurology, Akershus University Hospital, Lørenskog, Norway. e.s.kristoffersen@medisin.uio.no.ORCID http://orcid.org/0000-0002-8999-5424
University of Copenhagen · DKUniversity Hospital of Zurich · CHElisabeth-TweeSteden Ziekenhuis · NLHospital Clínico Universitario de Valladolid · ESHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRKlinikum Links der Weser · DEUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Bern · CHUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeadache is a frequent symptom following COVID-19 immunization with a typical onset within days post-vaccination. Cases of cerebral venous thrombosis (CVT) have been reported in adenovirus vector-based COVID-19 vaccine recipients.

findingsWe reviewed all vaccine related CVT published cases by April 30, 2021. We assessed demographic, clinical variables and the interval between the vaccination and onset of headache. We assessed whether the presence of headache was associated with higher probability of death or intracranial hemorrhage. We identified 77 cases of CVT after COVID-19 vaccination. Patients' age was below 60 years in 74/77 (95.8%) cases and 61/68 (89.7%) were women. Headache was described in 38/77 (49.4%) cases, and in 35/38 (92.1%) was associated with other symptoms. Multiple organ thrombosis was reported in 19/77 (24.7%) cases, intracranial hemorrhage in 33/77 (42.9%) cases and 19/77 (24.7%) patients died. The median time between vaccination and CVT-related headache onset was 8 (interquartile range 7.0-9.7) days. The presence of headache was associated with a higher odd of intracranial hemorrhage (OR 7.4; 95% CI: 2.7-20.8, p < 0.001), but not with death (OR: 0.51, 95% CI: 0.18-1.47, p = 0.213).

conclusionDelayed onset of headache following an adenovirus vector-based COVID-19 vaccine is associated with development of CVT. Patients with new-onset headache, 1 week after vaccination with an adenovirus vector-based vaccine, should receive a thorough clinical evaluation and CVT must be ruled out.

Indexed as

COVID-19VaccinesVenous ThrombosisCOVID-19 VaccinesFemaleHeadacheHumansMiddle AgedSARS-CoV-2VaccinationCOVID-19 VaccinesVaccinesCerebrovascular disorders; StrokeHeadache disordersSecondary; sinus thrombosisVaccine-induced immune thrombotic thrombocytopenia

Identifiers

PMID34535076
PMCPMC8446734
OpenAlexW3199618888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.